News | October 12, 2023
GlobalData predicts product cannibalization within electrophysiology ablation space
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
Subscribe To Our Newsletter & Stay Updated
